SCHEMBL9516950

SCHEMBL9516950

O=C(NS(=O)(=O)CCC(O)c1cc(Cl)cc(Cl)c1)c1ccc(CO)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.38
P4HTM Q9NXG6 6/20 0.36
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
FLT1 P17948 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
HDAC6 Q9UBN7 3/20 0.34
MAP4K4 O95819 2/20 0.33
ROCK2 O75116 1/20 0.33
RPS6KA5 O75582 1/20 0.33
PRKACA P17612 1/20 0.33
RPS6KB1 P23443 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9519314 0.95 EGFR (0.37) EGFRP4HTMADRB2ADRB1ADRB3
SCHEMBL9519674 0.91 EGFR (0.43) EGFRP4HTMADRB2ADRB1ADRB3
SCHEMBL9515755 0.89 EGFR (0.39) EGFRP4HTMADRB2ADRB1ADRB3
SCHEMBL9515897 0.86 EGFR (0.42) EGFRP4HTMADRB2ADRB1ADRB3
SCHEMBL9515637 0.85 EPHX2 (0.38) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9516716 0.83 EPHX2 (0.36) P4HTMADRB2ADRB1ADRB3MEN1
SCHEMBL9516279 0.82 HIF1A (0.39) P4HTMHDAC6PTGS1HDAC1HDAC4
SCHEMBL9519439 0.81 PNMT (0.42) HDAC6HDAC1
SCHEMBL9516977 0.80 EGFR (0.44) EGFRP4HTMMEN1NPC1RAB9A
SCHEMBL9518016 0.80 MEN1 (0.38) P4HTMMEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed